NNB Files New Patent for Plus LIFESPAN Ergothioneine and Ameliorating Mammalian Aging, Including Humans
Following the Ergothioniene Manufacturing Patent, NNB Files for a New Patent on Novel Applications for Plus LIFESPAN™ EGT that Include Restoring Ageing Conditions Similar to that of Young and Upregulating DNA Repair Pathways